Barclays raised the firm’s price target on NOV Inc. (NOV) to $13 from $12 and keeps an Underweight rating on the shares. The company posted some improvement in equipment orders as services spending remains subdued and demand for consumables slow with another year of flat global upstream spending, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOV:
- NOV Inc. price target raised to $18 from $17 at Piper Sandler
- NOV Inc. price target raised to $19 from $18 at Raymond James
- Balanced Outlook for NOV: Hold Rating Amid Growth Potential and Market Uncertainties
- NOV Inc. Reports Solid 2024 Financial Performance
- NOV Inc. Reports Strong Growth Amidst Industry Challenges